147 related articles for article (PubMed ID: 36207629)
1. Role of ultra-high b-value DWI in the imaging of hereditary leiomyomatosis and renal cell carcinoma (HLRCC).
Chaurasia A; Gopal N; Dehghani Firouzabadi F; Yazdian Anari P; Wakim P; Ball MW; Jones EC; Turkbey B; Huda F; Linehan WM; Turkbey EB; Malayeri AA
Abdom Radiol (NY); 2023 Jan; 48(1):340-349. PubMed ID: 36207629
[TBL] [Abstract][Full Text] [Related]
2. Magnetic Resonance Assessment of Peritoneal Carcinomatosis: Is There a True Benefit From Diffusion-Weighted Imaging?
Cianci R; Delli Pizzi A; Patriarca G; Massari R; Basilico R; Gabrielli D; Filippone A
Curr Probl Diagn Radiol; 2020; 49(6):392-397. PubMed ID: 31248709
[TBL] [Abstract][Full Text] [Related]
3. Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome: Spectrum of imaging findings.
Paschall AK; Nikpanah M; Farhadi F; Jones EC; Wakim PG; Dwyer AJ; Gautam R; Merino MJ; Srinivasan R; Linehan WM; Malayeri AA
Clin Imaging; 2020 Dec; 68():14-19. PubMed ID: 32562921
[TBL] [Abstract][Full Text] [Related]
4. The value of adding diffusion-weighted images for tumor detection and preoperative staging in renal pelvic carcinoma for the reader's experience.
Yoshida R; Yoshizako T; Maruyama M; Mori H; Ishikawa N; Tamaki Y; Kitagaki H
Abdom Radiol (NY); 2017 Sep; 42(9):2297-2304. PubMed ID: 28352951
[TBL] [Abstract][Full Text] [Related]
5. MR Spectroscopy for Detecting Fumarate Hydratase Deficiency in Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome.
Wu G; Liu G; Wang J; Pan S; Luo Y; Xu Y; Kong W; Sun P; Xu J; Xue W; Zhang J
Radiology; 2022 Dec; 305(3):631-639. PubMed ID: 35943337
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
[TBL] [Abstract][Full Text] [Related]
7. High signal renal tumors on DWI: the diagnostic value of morphological characteristics.
Zhang H; Pan J; Shen Y; Bai X; Wang Y; Wang H; Ye H
Abdom Radiol (NY); 2019 Jan; 44(1):239-246. PubMed ID: 30141057
[TBL] [Abstract][Full Text] [Related]
8. Image Quality Assessment of 2D
Hausmann D; Liu J; Budjan J; Reichert M; Ong M; Meyer M; Smakic A; Grimm R; Strecker R; Schoenberg SO; Wang X; Attenberger UI
Anticancer Res; 2018 Feb; 38(2):969-978. PubMed ID: 29374729
[TBL] [Abstract][Full Text] [Related]
9. Differentiating Benign from Malignant Renal Tumors Using T2- and Diffusion-Weighted Images: A Comparison of Deep Learning and Radiomics Models Versus Assessment from Radiologists.
Xu Q; Zhu Q; Liu H; Chang L; Duan S; Dou W; Li S; Ye J
J Magn Reson Imaging; 2022 Apr; 55(4):1251-1259. PubMed ID: 34462986
[TBL] [Abstract][Full Text] [Related]
10. Role of MR texture analysis in histological subtyping and grading of renal cell carcinoma: a preliminary study.
Goyal A; Razik A; Kandasamy D; Seth A; Das P; Ganeshan B; Sharma R
Abdom Radiol (NY); 2019 Oct; 44(10):3336-3349. PubMed ID: 31300850
[TBL] [Abstract][Full Text] [Related]
11. [Diffusion weighted imaging and perfusion weighted imaging in the differential diagnosis of benign and malignant renal masses on 3.0 T MRI].
Xu X; Wang P; Ma L; Shao Z; Zhang M
Zhonghua Yi Xue Za Zhi; 2015 Jan; 95(3):200-4. PubMed ID: 25877031
[TBL] [Abstract][Full Text] [Related]
12. Advanced Diffusion-Weighted Abdominal Imaging: Qualitative and Quantitative Comparison of High and Ultra-High b-Values for Lesion Detection and Image Quality.
Dreher C; Kuder TA; König F; Paech D; Tavakoli A; Laun FB; Flothow F; Gnirs R; Benkert T; Strecker R; Schlemmer HP; Bickelhaupt S
Invest Radiol; 2020 May; 55(5):285-292. PubMed ID: 32011572
[TBL] [Abstract][Full Text] [Related]
13. Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome-Associated Renal Cell Carcinoma Showing High FDG Uptake.
Xiao Z; Dong A; Wang Y
Clin Nucl Med; 2019 May; 44(5):420-423. PubMed ID: 30762823
[TBL] [Abstract][Full Text] [Related]
14. Low b-value (50-100) diffusion-weighted images detect significantly more hyperintense liver lesions in children than T2-weighted images.
Grasparil ADI; Gupta H; Sheybani E; Chavhan GB
Pediatr Radiol; 2019 Sep; 49(10):1299-1305. PubMed ID: 31292681
[TBL] [Abstract][Full Text] [Related]
15. Complete response of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case report.
Iribe Y; Furuya M; Shibata Y; Yasui M; Funahashi M; Ota J; Iwashita H; Nagashima Y; Hasumi H; Hayashi N; Makiyama K; Kondo K; Tanaka R; Yao M; Nakaigawa N
Fam Cancer; 2021 Jan; 20(1):75-80. PubMed ID: 32666341
[TBL] [Abstract][Full Text] [Related]
16. Renal cell carcinoma in young FH mutation carriers: case series and review of the literature.
Hol JA; Jongmans MCJ; Littooij AS; de Krijger RR; Kuiper RP; van Harssel JJT; Mensenkamp A; Simons M; Tytgat GAM; van den Heuvel-Eibrink MM; van Grotel M
Fam Cancer; 2020 Jan; 19(1):55-63. PubMed ID: 31792767
[TBL] [Abstract][Full Text] [Related]
17. Can diffusion-weighted magnetic resonance imaging of clear cell renal carcinoma predict low from high nuclear grade tumors.
Parada Villavicencio C; Mc Carthy RJ; Miller FH
Abdom Radiol (NY); 2017 Apr; 42(4):1241-1249. PubMed ID: 27904923
[TBL] [Abstract][Full Text] [Related]
18. Inter-observer variation and diagnostic efficacy of apparent diffusion coefficient (ADC) measurements obtained by diffusion-weighted imaging (DWI) in small renal masses.
Ponhold L; Javor D; Heinz-Peer G; Sevcenco S; Hofstetter M; Baltzer PA
Acta Radiol; 2016 Aug; 57(8):1014-20. PubMed ID: 26486599
[TBL] [Abstract][Full Text] [Related]
19. Characterization of indeterminate soft tissue masses referred for biopsy: What is the added value of contrast imaging at 3.0 tesla?
Del Grande F; Ahlawat S; Subhawong T; Fayad LM
J Magn Reson Imaging; 2017 Feb; 45(2):390-400. PubMed ID: 27417663
[TBL] [Abstract][Full Text] [Related]
20. Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry.
Chen YB; Brannon AR; Toubaji A; Dudas ME; Won HH; Al-Ahmadie HA; Fine SW; Gopalan A; Frizzell N; Voss MH; Russo P; Berger MF; Tickoo SK; Reuter VE
Am J Surg Pathol; 2014 May; 38(5):627-37. PubMed ID: 24441663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
